Andrew B. Benowitz
Impact in
- Hematology top 10%
- Multiple Myeloma Research and Treatments
-
- Peptidase Inhibition and Analysis
Papers in
-
- Protein Degradation and Inhibitors 8
- Ubiquitin and proteasome pathways 7
-
- Multiple Myeloma Research and Treatments 5
- Co-authors
- Steve Fidanze (3 shared papers)Yoshito Kishi (3 shared papers)John D. Harling (5 shared papers)Fengbin Song (2 shared papers)Markus A. Queisser (6 shared papers)Pamela L. C. Small (1 shared paper)Han Dai (4 shared papers)Jenni Cryan (2 shared papers)
- Journals
- Journal of the American Chemical Society (4 papers)Bioorganic & Medicinal Chemistry Letters (3 papers)SLAS DISCOVERY (2 papers)Organic Letters (2 papers)Tetrahedron Letters (1 paper)
- Partner nations
- United StatesUnited KingdomIreland
In The Last Decade
Andrew B. Benowitz
21 papers receiving 700 citations
Peers
Comparison fields: 5 of 67
- Hematology 98
- Oncology 207
- Molecular Biology 509
- Organic Chemistry 187
- Small Animals 32
Countries citing papers authored by Andrew B. Benowitz
This map shows the geographic impact of Andrew B. Benowitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew B. Benowitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew B. Benowitz more than expected).
Fields of papers citing papers by Andrew B. Benowitz
This network shows the impact of papers produced by Andrew B. Benowitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew B. Benowitz. The network helps show where Andrew B. Benowitz may publish in the future.
Co-authors
The 25 scholars most cited alongside Andrew B. Benowitz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 162 | |
| 2 | 2021 | 85 | |
| 3 | 2001 | 70 | |
| 4 | 2020 | 67 | |
| 5 | 2002 | 55 | |
| 6 | 2020 | 50 | |
| 7 | 1999 | 37 | |
| 8 | 2020 | 36 | |
| 9 | 2007 | 27 | |
| 10 | 2013 | 20 | |
| 11 | 1997 | 19 | |
| 12 | 1998 | 18 | |
| 13 | 2005 | 13 | |
| 14 | 2000 | 12 | |
| 15 | 2018 | 11 | |
| 16 | 2013 | 9 | |
| 17 | 2021 | 5 | |
| 18 | 2019 | 5 | |
| 19 | 2018 | 5 | |
| 20 | 2021 | 4 |
About Andrew B. Benowitz
Andrew B. Benowitz is a scholar working on Molecular Biology, Hematology, Organic Chemistry, Pharmacology and Oncology, having authored 22 papers that have together received 714 indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (8 papers), Ubiquitin and proteasome pathways (7 papers), Multiple Myeloma Research and Treatments (5 papers), Peptidase Inhibition and Analysis (3 papers), Microbial Natural Products and Biosynthesis (3 papers), T-cell and B-cell Immunology (3 papers), Immune Cell Function and Interaction (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). The work is most often cited by research in Hematology (98 citations), Oncology (207 citations), Molecular Biology (509 citations), Organic Chemistry (187 citations) and Small Animals (32 citations). Andrew B. Benowitz has collaborated with scholars based in United States, United Kingdom and Ireland. Frequent co-authors include Steve Fidanze, Yoshito Kishi, John D. Harling, Fengbin Song, Markus A. Queisser, Pamela L. C. Small, Han Dai, Jenni Cryan, Katherine L. Jones and Amos B. Smith. Their work appears in journals such as Journal of the American Chemical Society, Bioorganic & Medicinal Chemistry Letters, SLAS DISCOVERY, Organic Letters and Tetrahedron Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.